The effect of various forms of thrombin on certain platelet functions has been investigated. Partially purified bovine thrombin, which is a mixture of multiple active forms of thrombin, was chromatographed to yield molecular species termed a-, A-, and y-thrombin, each of which has varying degrees of fibrinogen clotting and esterase activities. A direct correlation was observed between the ability of the different forms of thrombin to clot fibrinogen and to influence platelet function. In general, thrombin with high fibrinogen clotting activity was also a potent inducer of platelet aggregation and the release reaction, while those species with low clotting ability were poor inducers of aggregation and release. On the other hand, thrombin with both fibrinogen clotting activity and esterase activity nearly completely inactivated by treatment with N--ptosyl-L-ysine chloromethyl ketone ha no aggregation or release inductive ability. Studies performed with partly purified thrombin or individual species of thrombin iodinated with 125I indicated that despite differences in fibrinogen clotting activities, a-thrombin and its degraded forms were capable of binding to the platelet surface. The possibility exists that thrombin binding to the platelet surface may be a means of strategically anchoring and concentrating large amounts of enzymatically active thrombin within the white thrombus at a site of vascular injury.
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The plasma membrane is the primary site of action of many agents that affect platelet function. Biologically important agents that are known to influence platelet function include thrombin, adenosine diphosphate (ADP), collagen, epinephrine, and serotonin (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Thrombin, a proteolytic enzyme pivotal in the blood coagulation reaction and a potent inducer of platelet aggregation and release, also interacts with the platelet plasma membrane and liberates a small glycoprotein (5) (6) (7) (8) . Recently, Tollefsen et al. (9) , and Ganguly (10) have reported that thrombin or thrombin inhibited by diisopropylphosphofluoridate (Dip-F) or phenylmethylsulfonyl fluoride (Phe-S02-F) is capable of tightly binding to the platelet surface. It has become apparent that thrombin can be isolated in several different molecular forms which differ significantly in fibrinogen-clotting and esterase activity (11) (12) (13) (14) (15) (16) (17) (18) . Since the effect of these different species of thrombin on platelet functions has not been determined, the present studies were initiated to compare the platelet aggregating, release inducing, and membrane binding properties of these forms of thrombin.
Studies performed with partially purified thrombin and with (23) after alkaline hydrolysis (24) using crystalline bovine serum albumin (Pentex; Miles Laboratories, Elkhart, Ind.) as a standard. aThrombin was inactivated by Tos-LysCH2Cl as described by Glover and Shaw (13) .
In view of differences in the fibrinogen clotting activity per mg of protein (NIH units) in various thrombin preparations and for the sake of clarity and comparison, results will be expressed in terms of nM concentrations of the various thrombins. A value of 39,000 daltons was used for a-thrombin while a value of 28,000 daltons was used for both (3- and -y-thrombins (14) .
Platelet Aggregation. Platelet aggregation was studied by the use of a Payton dual channel aggregometer at 37'. The rations was examined by adding 0.05 ml of a thrombin solution in saline (0.154 M NaCl) to 0.45 ml of a platelet suspension containing 400,000 platelets per jil. Percent The resultant supernatant was discarded and the sedimented platelets were resuspended in 2 ml of MFTS and incubated again for 10 min at 370. An additional 2.7 mM EDTA was added immediately prior to the next centrifugation at 820 X g for 2 min. This supernatant was discarded also and the sedimented platelets were resuspended in 1.6 ml of MFTS. An aliquot was removed from this control tube to determine the final platelet count. This platelet count, performed in duplicate, was used to determine the amount of thrombin bound to the surfaces of individual platelets. Washing of platelets up to 10 times did not change significantly the amount of labeled thrombin bound to their surfaces. After the first washing procedure, platelet suspensions were transferred to fresh, unused, silicone-coated tubes to eliminate the possibility of non-specific binding of free 125I-labeled thrombin to container walls.
Washed erythrocytes were exposed to the '25I-labeled thrombin, rewashed under the same conditions as described above, and examined for bound 125I-labeled thrombin. Less than 1% of the amount of 125I bound to platelets was found associated with erythrocytes when comparison was made on the basis of cell counts.
RESULTS
Effects of unmodified and modified thrombin on platelet functions (a) Platelet Aggregation. A direct correlation was observed between the fibrinogen clotting activity and the ability of a particular thrombin preparation to induce platelet aggregation. Partially purified thrombin and a-thrombin were potent platelet aggregating agents (Fig. 1) . At approximately 5 nM concentration, nearly a maximal degree of platelet aggregation by platelets under the influence of a range of concentrations of the various thrombins revealed a pattern similar to that obtained in platelet aggregation studies. These release inducing activities of the different forms of thrombin were directly proportional to their fibrinogen clotting activities. At 10 nM concentration, both paily purified thrombin and a-thrombin induced nearly a maximal degree of release (Table 1) . ftThrombin was less effective, whereas y-thrombin was a poor inducer of release. No release of [14C]serotonin was observed with concentrations of Tos-LysCH2CI a-thrombin up to 50 nM. Binding of various thrombins to the platelet surface The various forms of thrombin were capable of binding to the platelet surface irrespective of their fibrinogen clotting or esterase activities. Overall, the binding ability of thrombins with high fibrinogen clotting activity was poor, the only exception being 'y-thrombin which was found to have a binding pattern similar to that of a-thrombin or partially purified thrombin. Determination of the number of molecules of each of the various types of thrombin bound to the surface of platelets indicated that the binding efficiency of thrombin and partially purified thrombin was less than that of fl-or Tos-LysCH2CI-a-thrombin (Fig. 2) . Exposure of platelet suspensions to a maximum 400 nM concentration of a-thrombin or a 200 nM concentration of Tos-LysCH2CI inactivated a-thrombin showed no indication of saturation of the binding sites under these experimental conditions (Fig. 3) . It was also observed that the thrombin binding efficiency of platelets was better at lower than at higher thrombin concentrations. Platelets obtained from afibrinogenemic and thrombasthenic patients were investigated also for their ability to bind thrombin. Preliminary studies on the binding of a-and Tos-LysCH2Cl-a-thrombin to these platelets indicated a pattern similar to that observed in studies with normal platelets. 
DISCUSSION
The ability of (3- or y-thrombin to cause weak platelet aggregation and to induce the release reaction at molar concentrations higher than that of a-thrombin is probably due to the residual fibrinogen-clotting activity of these proteins. If we consider that (3- and y-thrombin possess approximately 5-10%
of the fibrinogen-clotting activity of a-thrombin, and if one assumes that there is a direct correlation between the ability to aggregate platelets and the ability to clot fibrinogen, then one would expect, irrespective of binding capability, that it would require some 20-fold more (3- or y-thrombin than a-thrombin to elicit the same physiological response. That is, in fact, what is observed in the current experiments. It is also possible that the residual fibrinogen clotting activity present in the preparations of (3- and y-thrombin is due to contamination by small amount of a-thrombin. This is considered unlikely, but does not affect the argument regarding the relationship between the physiological action of thrombin on platelets and the ability to clot fibrinogen. Binding affinities of the various forms of thrombin for the platelet surface indicated generally a reverse pattern to that obtained in studies of platelet aggregation and release. The preparations of thrombin with high fibrinogen clotting activity appeared to bind to the platelet surface less efficiently than those with little or no fibrinogen clotting activity; the behavior of 'y-thrombin being an unexplained exception of this rule. Since partially purified thrombin and a-thrombin are capable of inducing rapid aggregation, it is highly likely that in the presence of these forms of thrombin the platelet surface undergoes rapid secondary changes that are eventually manifested as aggregation and the release reaction. Apparently, similar.secondary changes are not induced by (3-, y-, or Tos- LysCH2Cl-a-thrombins. Thus, it is possible that the decreased binding of partially purified thrombin or a-thrombin that was ultimately quantitated may be due to the secondary changes induced by these molecules on the platelet surface. Of interest also is the fact that Tollefsen and coworkers (9) have reported a similar binding affinity for partially purified thrombin and for thrombin inhibited by Dip-F. The only conclusion drawn by binding studies presented here is that various thrombins with varying degrees of fibrinogen clotting and esterase activities are capable of binding to platelet surfaces. It is realized that more detailed and critical studies will have to be carried out before the differences in the binding affinities of various thrombins could be considered meaningful.
Our failure to observe saturation of binding sites on the platelet plasma membrane raises the question of whether new binding sites may be uncovered as exposed sites are saturated with bound thrombin. Ganguly (10) has reported similar observations with washed platelets exposed to partially purified thrombin, although he observed a saturation when platelets were in plasma. Platelets in plasma were not used in the present study due to the inherent complexity of this medium. Failure to demonstrate binding saturation is unsettling and deserves further investigation.
Internalization of labeled thrombin by platelets is another possible explanation for failure to demonstate saturation of binding sites. While this possibility cannot be ruled out completely, it appears unlikely in light of the work of others (9) branes by autoradiography. These workers (9) 
